Literature DB >> 29484221

Peyronie's disease surgery: Surgical outcomes of 268 cases.

Ateş Kadıoğlu1, Emre Salabaş2, Abdulkadir Özmez1, Abdullah Feyyaz Ural3, Ömer Barış Yücel1, Mazhar Ortaç4, Yaşar Pazır1, Bahadır Ermeç5.   

Abstract

OBJECTIVE: To assess the outcomes of the surgical techniques used in Peyronie's disease (PD) surgery.
MATERIAL AND METHODS: Two hundred and sixty-eight patients received surgical treatment for PD. Fifty four and 144 patients underwent simple corporoplasties (shortening procedure, SP, group 1) or plaque incision and grafting surgery (lengthening surgery, LP, group 2), respectively, whereas 70 patients with erectile dysfunction underwent penile prosthesis implantation.
RESULTS: Penile plication and Nesbit surgeries were performed in 5 (9%) and 42 (78%) patients out of total 54 patients. In the remaining 7 (13%) patients, Nesbit and plication suture combination was required for complete penile straightening. Mean curvature degree was 52.2±12.3 degrees. Follow up time was 36.1±29.4 months. No significant difference was demonstrated between the two groups in the baseline features and co-morbidities except age. In 144 patients who underwent plaque incision and grafting, mean age and PD onset duration were 54.1±9.2 years and 28.2±17.3 months respectively. Mean curvature degree was 58.4±18.9 degrees. Post-operative follow up time of the second group was 51.1±39.6 months. Additional plication suture was used in 48 patients (33%) patients. Degree of curvature improvement was 37.9±19.1 and 52.1±23.5 in SP and LP respectively (p=0.01). The initial anatomic success rates were 90.4% and 87.5% at their early post-operative follow-ups for group 1 and 2 respectively. These rates dropped to 82.7% and 83.6% at the long term follow-up (36 and 51 months) respectively (p=0.9). Although the average follow-up time of LP group was longer than SP group (52.1 mo vs. 37.0 mo), recurrence rates of these two groups were comparable. The combined functional and anatomical success of patients were demonstrated to be 79% and 75% in shortening and grafting surgery. Shortening surgery was not statistically superior to grafting surgery for patients in terms of having erection with or without the aid of PDE-5 inhibitors (94.4% vs. 88.2%, p=0.28). Shortening surgery makes a difference in the long term follow-up for patients who had erections without the aid of PDE-5 inhibitors (90.7% vs. 67.3%, p=0.02).
CONCLUSION: Both SP and LP are successful in terms of penile straightening in the short and long-term follow-up. Curvature degree improvement is greater in LP. Patients who undergo LP surgery may suffer from ED in the long-term follow-ups. Greater percentage of patients who underwent LP require PDE-5 inhibitors usage for sexual intercourse. Despite stated shortcomings, combined success (anatomic and functional) is achieved in three out of four patients for both groups. Penile prosthesis implantation should be preferred for patients with ED and penile deformity.

Entities:  

Keywords:  Erectile dysfunction; Nesbit; Peyronie’s disease; grafting

Year:  2017        PMID: 29484221      PMCID: PMC5821276          DOI: 10.5152/tud.2018.87405

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  23 in total

1.  Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease.

Authors:  F Montorsi; A Salonia; T Maga; L Bua; G Guazzoni; L Barbieri; G Barbagli; R Chiesa; G Pizzini; P Rigatti
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

2.  Modified Nesbit procedure for the treatment of Peyronie's disease: a comparative outcome analysis.

Authors:  M R Licht; R W Lewis
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

Review 3.  Graft materials in Peyronie's disease surgery: a comprehensive review.

Authors:  Ates Kadioglu; Oner Sanli; Tolga Akman; Ahmet Ersay; Selcuk Guven; Firdovsi Mammadov
Journal:  J Sex Med       Date:  2007-04-06       Impact factor: 3.802

Review 4.  Nonsurgical treatment options in Peyronie's Disease: 2016 update.

Authors:  Raidh A Talib; Mohammed Abdulkareem Ibrahim; Önder Cangüven
Journal:  Turk J Urol       Date:  2016-12

5.  10 Years' Plaque Incision and Vein Grafting for Peyronie's Disease: Does Time Matter?

Authors:  Florian Wimpissinger; Arie Parnham; Georg Gutjahr; Sandra Maksys; Martin Baierlein; Walter Stackl
Journal:  J Sex Med       Date:  2016-01       Impact factor: 3.802

6.  Evidence-Based Management Guidelines on Peyronie's Disease.

Authors:  Eric Chung; David Ralph; Ates Kagioglu; Guilio Garaffa; Ahmed Shamsodini; Trinity Bivalacqua; Sidney Glina; Lawrence Hakim; Hossein Sadeghi-Nejad; Gregory Broderick
Journal:  J Sex Med       Date:  2016-06       Impact factor: 3.802

7.  Straightening corporoplasty for Peyronie's disease: a review of 218 patients with median follow-up of 89 months.

Authors:  Gianfranco Savoca; Francesco Scieri; Francesco Pietropaolo; Giulio Garaffa; Emanuele Belgrano
Journal:  Eur Urol       Date:  2004-11       Impact factor: 20.096

8.  The Nesbit operation for Peyronie's disease: 16-year experience.

Authors:  D J Ralph; M al-Akraa; J P Pryor
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

9.  Venous patch graft for Peyronie's disease. Part II: outcome analysis.

Authors:  A I El-Sakka; H M Rashwan; T F Lue
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

Review 10.  Grafting techniques for Peyronie's disease.

Authors:  Georgios Hatzichristodoulou
Journal:  Transl Androl Urol       Date:  2016-06
View more
  2 in total

Review 1.  ESSM Position Statement on Surgical Treatment of Peyronie's Disease.

Authors:  Daniar Osmonov; Ahmed Ragheb; Sam Ward; Gideon Blecher; Marco Falcone; Armin Soave; Roland Dahlem; Koenraad van Renterghem; Nim Christopher; Georgios Hatzichristodoulou; Mirko Preto; Giulio Garaffa; Maarten Albersen; Carlo Bettocchi; Giovanni Corona; Yacov Reisman
Journal:  Sex Med       Date:  2021-11-22       Impact factor: 2.491

Review 2.  Management of residual penile curvature after penile prosthesis placement.

Authors:  Denis V Krakhotkin; David J Ralph; Gideon A Blecher; Volodymyr A Chernylovskyi; Francesco Greco; Evgeny E Bakurov; Ruslan A Bugaev
Journal:  Asian J Androl       Date:  2021 Mar-Apr       Impact factor: 3.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.